Literature DB >> 11704922

Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

R A Hegele1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704922      PMCID: PMC1235529          DOI: 10.1086/324647

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  183 in total

Review 1.  Tangier disease as a test of the reverse cholesterol transport hypothesis.

Authors:  A R Tall; N Wang
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Remnant lipoproteins as therapeutic targets.

Authors:  R J Havel
Journal:  Curr Opin Lipidol       Date:  2000-12       Impact factor: 4.776

3.  Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration.

Authors:  R A Hegele; W C Breckenridge; J H Brunt; P W Connelly
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

4.  Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2).

Authors:  P Oelkers; L C Kirby; J E Heubi; P A Dawson
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex.

Authors:  E M Wijsman; J D Brunzell; G P Jarvik; M A Austin; A G Motulsky; S S Deeb
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-02       Impact factor: 8.311

6.  No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.

Authors:  P Pajukanta; K V Porkka; M Antikainen; M R Taskinen; M Perola; S Murtomäki-Repo; S Ehnholm; I Nuotio; L Suurinkeroinen; A T Lahdenkari; A C Syvänen; J S Viikari; C Ehnholm; L Peltonen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-05       Impact factor: 8.311

7.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Authors:  S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

8.  Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group.

Authors:  J Vakkilainen; K V Porkka; I Nuotio; P Pajukanta; L Suurinkeroinen; K Ylitalo; J S Viikari; C Ehnholm; M R Taskinen
Journal:  Eur J Clin Invest       Date:  1998-01       Impact factor: 4.686

9.  Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.

Authors:  L W Castellani; A Weinreb; J Bodnar; A M Goto; M Doolittle; M Mehrabian; P Demant; A J Lusis
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

10.  Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.

Authors:  P Pajukanta; I Nuotio; J D Terwilliger; K V Porkka; K Ylitalo; J Pihlajamäki; A J Suomalainen; A C Syvänen; T Lehtimäki; J S Viikari; M Laakso; M R Taskinen; C Ehnholm; L Peltonen
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

View more
  16 in total

1.  Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia.

Authors:  Yuko Fujita; Yoichi Ezura; Hideaki Bujo; Toshiaki Nakajima; Kaneo Takahashi; Kouhei Kamimura; Yasuhiko Iino; Yasuo Katayama; Yasushi Saito; Mitsuru Emi
Journal:  J Hum Genet       Date:  2005-04-14       Impact factor: 3.172

2.  What We Know About Diet, Genes, and Dyslipidemia: Is There Potential for Translation?

Authors:  Toni I Pollin; Michael Quartuccio
Journal:  Curr Nutr Rep       Date:  2013-12

Review 3.  The role of triglycerides in cardiovascular risk.

Authors:  Puneet Gandotra; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

4.  Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene.

Authors:  Yuko Fujita; Yoichi Ezura; Mitsuru Emi; Keiko Sato; Daisuke Takada; Yasuhiko Iino; Yasuo Katayama; Kaneo Takahashi; Kouhei Kamimura; Hideaki Bujo; Yasushi Saito
Journal:  J Hum Genet       Date:  2003-12-06       Impact factor: 3.172

5.  Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.

Authors:  Keiko Sato; Mitsuru Emi; Yoichi Ezura; Yuko Fujita; Daisuke Takada; Tomoaki Ishigami; Satoshi Umemura; Yunpei Xin; Lily L Wu; Stacey Larrinaga-Shum; Susan H Stephenson; Steven C Hunt; Paul N Hopkins
Journal:  J Hum Genet       Date:  2003-12-13       Impact factor: 3.172

6.  Hypertriglyceridemia associated with amino acid variation Asn985Tyr of the RP1 gene.

Authors:  Yuko Fujita; Yoichi Ezura; Mitsuru Emi; Shuji Ono; Daisuke Takada; Kaneo Takahashi; Kouhei Uemura; Yasuhiko Iino; Yasuo Katayama; Hideaki Bujo; Yasushi Saito
Journal:  J Hum Genet       Date:  2003-05-23       Impact factor: 3.172

7.  Hypertriglyceridemia: phenomics and genomics.

Authors:  Robert A Hegele; Rebecca L Pollex
Journal:  Mol Cell Biochem       Date:  2009-01-07       Impact factor: 3.396

Review 8.  Hypertriglyceridemia: its etiology, effects and treatment.

Authors:  George Yuan; Khalid Z Al-Shali; Robert A Hegele
Journal:  CMAJ       Date:  2007-04-10       Impact factor: 8.262

9.  A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia.

Authors:  Shuji Ono; Yoichi Ezura; Mitsuru Emi; Yuko Fujita; Daisuke Takada; Keiko Sato; Tomoaki Ishigami; Satoshi Umemura; Kaneo Takahashi; Kouhei Kamimura; Hideaki Bujo; Yasushi Saito
Journal:  J Hum Genet       Date:  2003-09-03       Impact factor: 3.172

10.  Hypertriglyceridemia-induced recurrent acute pancreatitis: A case-based review.

Authors:  Sunil K Kota; Siva K Kota; Sruti Jammula; S V S Krishna; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.